Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Senseonics. A complete text table follows the diagram.
Implantable glucose-monitoring systems and diabetes technology define Senseonics' medical-device platform.
Swipe to explore
The operating total is tied to the filing; the destination is an editorial label for the disclosed business engine, with no invented segment allocation.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Reported operating total | 1 | $4.8M | Directly reported in the downloaded 10-Q |
| continuous-glucose monitoring platform | 2 | $4.8M | Implantable glucose-monitoring systems and diabetes technology define Senseonics' medical-device platform. |
| From | To | Value |
|---|---|---|
| Reported operating total | continuous-glucose monitoring platform | $4.8M |